Neoplasias
3.
4.
5.
6.
7.
8.
9. 10. 11.
12.
13.
14. 15.
Grune & Stratton. Nueva York. 1983. págs. 245260. Grupo de Trabajo de la SEPAR. Normativa actualizada (1998) sobre diagnóstico y estadificación del carcinoma broncogénico. Arch Bronconeumol 1998; 34:437-452. Lung Cancer Study Group (prepared by Ginsberg RJ, Rubinstein LV). Randomized trial of lobectomy versus limited resection for T1N0 non-small cell lung cancer. Ann Thorac Surg 1995; 60:615-622. Izbicki JR, Passlick B, Karg O, et al. Impact of radical systematic mediastinal lymphadenectomy on tumor staging in lung cancer. Ann Thorac Surg 1995; 59:209-214. Izbicki JR, Passlick B, Pantel K, et al. Effectiveness of radical systematic mediastinal lymphadenectomy in patients with resectable non-small lung cancer. Ann Surg 1998; 227:138-144. Keller SM, Adak S, Wagner H, et al., for the Eastern Cooperative Oncology Group. Mediastinal lymph node dissection improves survival in patients with stages II and IIIa non-small cell lung cancer. Ann Thorac Surg 2000; 70:358-366. Wu Y, Huang ZF, Wang SY, et al. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer 2002; 36:1-6. Goldstraw P. Report on the International workshop on intrathoracic staging. London, October 1996. Lung Cancer 1997; 18:107-111. Sobin LH, Wittekind Ch. TNM classification of malignant tumours. Sexta edición. Wiley-Liss. Nueva York. 2002. págs. 97-103. Grupo Cooperativo de Carcinoma Broncogénico de la Sociedad Española de Neumología y Cirugía Torácica (GCCB-S). Estadificación ganglionar intraoperatoria en la cirugía del carcinoma broncogénico. Documento de consenso. Arch Bronconeumol 2001; 37:495-503. López Encuentra Á, Linares Asensio MJ. Carcinoma broncogénico. En: Martín Escribano P, López Encuentra Á, Editores. Pautas de práctica clínica en neumología. (Algoritmos clínicos y procedimientos). IDEPSA. Madrid. 1996. págs. 177-185. Barberá Mir JA, Ribas Sola J. Criterios actuales para la operabilidad funcional. En: López Encuentra Á, Llobregat Poyán N, Editores. Cáncer de pulmón. Ediciones Doyma, SA. Barcelona. 2002. págs. 96-109. Ninane V, Le Pechoux C, Curran W, et al. Critical factors for patient management. Lung Cancer 2003; 42 (Suppl. 1):s7-s8. Rami Porta R, Mateu Navarro M, González Pont G. Estadios tumorales, estadificación clínica y patológica. Pronóstico. En: López Encuentra Á, Llobregat Poyán N, Editores. Cáncer de pulmón. Ediciones Doyma, SA. Barcelona. 2002; págs. 71-95.
1110
16. Postmus PE, Rocmans P, Asamura H, et al. Consensus report IASLC workshop Bruges, September 2002: pretreatment minimal staging for non-small cell lung cancer. Lung Cancer 2003; 42 (Suppl.1): s3-s6. 17. Sagawa M, Koike T, Sato M, et al. Segmentectomy for roentgenographically occult bronchogenic squamous cell carcinoma. Ann Thorac Surg 2001; 71:1100-1104. 18. López-Encuentra Á, Duque-Medina JL, RamiPorta R, et al. Staging in lung cancer: is 3 cm a prognostic threshold in pathologic stage I nonsmall cell lung cancer? A multicenter study of 1,020 patients. Chest 2001; 1515-1520. 19. Tronc F, Grégoire J, Rouleau J, et al. Long-term results of sleeve lobectomy for lung cancer. Eur J Cardiothorac Surg 2000; 17:550-556. 20. Krüger M, Uschinsky K, Hässler K, et al. Postoperative complications after bronchoplastic procedures in the treatment of bronchial malignancies. Eur J Cardiothorac Surg 1998; 14:46-53. 21. Roviaro G, Varoli F, Romanelli A, et al. Complications of tracheal sleeve pneumonectomy: personal experience and overview of the literature. J Thorac Cardiovascular Surg 2001; 121:234-240. 22. Andre F, Grunenwald D, Pigon JP, et al. Survival of patients with resected N2 non-small cell lung cancer: evidence for a subclassification and implications. J Clin Oncol 2000; 18:2981-2989. 23. Pass HI, Pogrebniak HW, Steinberg SM, et al. Randomized trial of neoadjuvant therapy for lung cancer: interim analysis. Ann Thorac Surg 1992; 53:992-998. 24. Depierre A, Milleron B, Moro-Sibilot D, et al. Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small cell lung cancer. J Clin Oncol 2001; 20:247-253. 25. Roth JA, Atkinson EN, Fossella F, et al. Longterm follow up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small cell lung cancer. Lung Cancer 1998; 21:1-6. 26. Rosell R, Gómez-Codina J, Camps C, et al. Preresectional chemotherapy in stage IIIA nonsmall cell lung cancer: a 7-year assessment of a randomized controlled trial. Lung Cancer 1999; 47:7-14. 27. Albain KS, Scott CB, Rusch VR, et al. Phase III study of concurrent chemotherapy and full course radiotherapy (CT/RT) versus CT/RT induction followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): First outcome analysis of North American Intergroup trial 0139 (RTOG 93-09). Lung Cancer 2003; 41 (Suppl. 2): s4. 28. Mateu-Navarro M, Rami-Porta R, Bastus-Piulats R, et al. Remediastinoscopy after induction